Cicin I, Plimack ER, Gurney H, Leibowitz R, et al. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study. BMC Cancer 2024;23.
PMID: 39054485